ESTRO 2025 - Abstract Book

S3093

Physics - Inter-fraction motion management and offline adaptive radiotherapy

ESTRO 2025

Conclusion: CBCT-based oART enhances dosimetric outcomes in esophageal cancer by allowing reduced PTV margins while adjusting for interfraction variability, which results in improved target coverage and reduced radiation exposure to OARs.

Keywords: online adaptive, esophageal cancer

References: [1] P. van Hagen, M. Hulshof, J. van Lanschot, E. Steyerberg, M. van Berge Henegouwen, B. Wijnhoven en D. Richel, „Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer,” The New England Journal of Medicine, vol. May, nr. Vol. 336 No. 22, 2012. [2] J. Shapiro, J. van Lanschot, M. Hulshof, P. van Hagen, M. van Berge Henegouwen, B. Wijnhoven, H. van Laarhoven, G. Nieuwenhuijzen, .... E. Bilgen, H. van Dekken en A. van der Gaast, „Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial,” The Lancet Oncology, vol. 16, nr. 9, pp. 1090-1098, 2015.